KRAS and pancreatic neoplasm: Activating mutations of K-ras are the earliest consistently detected abnormality in the development of pancreatic cancer, and pancreatic cancers that spontaneously develop in mice with genetically-modified K-ras show similar features to those seen in patients [2].